In addition, miR-18a/PTEN axis has been reported to induce the sensitivity of NSCLC cells to cisplatin by stimulating the tumor protein 53 target gene 1 (Xiao et al., 2018). The gene discussed is PTEN; the disease is non-small cell lung carcinoma.